JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

Search

Simulations Plus Inc

Închisă

SectorSănătate

17.15 -2.5

Rezumat

Modificarea prețului

24h

Curent

Minim

17.15

Maxim

18.24

Indicatori cheie

By Trading Economics

Venit

-70M

-67M

Vânzări

-2.1M

20M

P/E

Medie Sector

48.528

37.461

Randament dividend

0.48

Marjă de profit

-330.585

Angajați

243

EBITDA

-79M

-74M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

-9.19% downside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.48%

2.33%

Următoarele câștiguri

29 oct. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-28M

323M

Deschiderea anterioară

19.65

Închiderea anterioară

17.15

Sentimentul știrilor

By Acuity

38%

62%

133 / 371 Clasament în Healthcare

Simulations Plus Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 oct. 2025, 22:47 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 oct. 2025, 22:13 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 oct. 2025, 21:20 UTC

Câștiguri

Correction to IBM 3Q Sales Jump Article

22 oct. 2025, 20:57 UTC

Câștiguri

SAP Posts Higher 3Q Revenue, Operating Profit

22 oct. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 oct. 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 oct. 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 oct. 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 oct. 2025, 23:15 UTC

Câștiguri

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 oct. 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 oct. 2025, 22:02 UTC

Câștiguri

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 oct. 2025, 21:59 UTC

Achiziții, Fuziuni, Preluări

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 oct. 2025, 21:58 UTC

Achiziții, Fuziuni, Preluări

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 oct. 2025, 21:57 UTC

Achiziții, Fuziuni, Preluări

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 oct. 2025, 21:56 UTC

Achiziții, Fuziuni, Preluări

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 oct. 2025, 21:47 UTC

Achiziții, Fuziuni, Preluări

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 oct. 2025, 21:47 UTC

Câștiguri

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 oct. 2025, 21:47 UTC

Achiziții, Fuziuni, Preluări

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 oct. 2025, 21:46 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 oct. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 oct. 2025, 21:45 UTC

Achiziții, Fuziuni, Preluări

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 oct. 2025, 21:28 UTC

Market Talk
Câștiguri

Correction to Alcoa Tariff Market Talk

22 oct. 2025, 21:25 UTC

Câștiguri

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 oct. 2025, 21:17 UTC

Câștiguri

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 oct. 2025, 21:09 UTC

Market Talk
Câștiguri

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 oct. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22 oct. 2025, 20:59 UTC

Câștiguri

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 oct. 2025, 20:51 UTC

Câștiguri

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 oct. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 oct. 2025, 20:44 UTC

Câștiguri

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Comparație

Modificare preț

Simulations Plus Inc Așteptări

Obiectiv de preț

By TipRanks

-9.19% jos

Prognoză pe 12 luni

Medie 16 USD  -9.19%

Maxim 16 USD

Minim 16 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSimulations Plus Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

3 ratings

2

Cumpărare

1

Păstrare

0

Vânzare

Sentiment

By Acuity

133 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat